6.
Chan J, Seidah N, Chretien M
. Measurement of N-terminal (1-76) of human proopiomelanocortin in human plasma: correlation with adrenocorticotropin. J Clin Endocrinol Metab. 1983; 56(4):791-6.
DOI: 10.1210/jcem-56-4-791.
View
7.
Lowry P, Silas L, Mclean C, Linton E, Estivariz F
. Pro-gamma-melanocyte-stimulating hormone cleavage in adrenal gland undergoing compensatory growth. Nature. 1983; 306(5938):70-3.
DOI: 10.1038/306070a0.
View
8.
Chang A, Cochet M, Cohen S
. Structural organization of human genomic DNA encoding the pro-opiomelanocortin peptide. Proc Natl Acad Sci U S A. 1980; 77(8):4890-4.
PMC: 349954.
DOI: 10.1073/pnas.77.8.4890.
View
9.
Motomatsu T, Takahashi H, IBAYASHI H, Nobunaga M
. Human plasma proopiomelanocortin N-terminal peptide and adrenocorticotropin: circadian rhythm, dexamethasone suppression, and corticotropin-releasing hormone stimulation. J Clin Endocrinol Metab. 1984; 59(3):495-8.
DOI: 10.1210/jcem-59-3-495.
View
10.
Rivier C, Brownstein M, Spiess J, Rivier J, Vale W
. In vivo corticotropin-releasing factor-induced secretion of adrenocorticotropin, beta-endorphin, and corticosterone. Endocrinology. 1982; 110(1):272-8.
DOI: 10.1210/endo-110-1-272.
View
11.
Hale A, Ratter S, Tomlin S, Lytras N, Besser G, Rees L
. Measurement of immunoreactive gamma-MSH in human plasma. Clin Endocrinol (Oxf). 1984; 21(2):139-48.
DOI: 10.1111/j.1365-2265.1984.tb03453.x.
View
12.
Fallo F, Sonino N, Armanini D, Luzzi T, Pedini F, Pasini C
. A new family with dexamethasone-suppressible hyperaldosteronism: aldosterone unresponsiveness to angiotensin II. Clin Endocrinol (Oxf). 1985; 22(6):777-85.
DOI: 10.1111/j.1365-2265.1985.tb00168.x.
View
13.
Takahashi H, Teranishi Y, Nakanishi S, Numa S
. Isolation and structural organization of the human corticotropin--beta-lipotropin precursor gene. FEBS Lett. 1981; 135(1):97-102.
DOI: 10.1016/0014-5793(81)80952-0.
View
14.
Griffing G, Berelowitz B, Hudson M, Salzman R, Manson J, Aurrechia S
. Plasma immunoreactive gamma melanotropin in patients with idiopathic hyperaldosteronism, aldosterone-producing adenomas, and essential hypertension. J Clin Invest. 1985; 76(1):163-9.
PMC: 423734.
DOI: 10.1172/JCI111941.
View
15.
Benjannet S, Seidah N, Routhier R, Chretien M
. A novel human pituitary peptide containing the gamma-MSH sequence. Nature. 1980; 285(5764):415-6.
DOI: 10.1038/285415a0.
View
16.
Ekman R, Hakanson R, Larsson I, Sundler F, Thorell J
. Radioimmunoassay of pro-gamma-melanotropin, the amino-terminal fragment of proopiolipomelanocortin. Endocrinology. 1982; 111(2):578-83.
DOI: 10.1210/endo-111-2-578.
View
17.
Hope J, Estivariz F, Lowry P, Edwards C
. Circulating human pituitary pro-gamma-melanotropin enhances the adrenal response to ACTH. Nature. 1981; 291(5811):156-9.
DOI: 10.1038/291156a0.
View
18.
Bertagna X, Girard F, Seurin D, LUTON J, BRICAIRE H, Mains R
. Evidence for a peptide similar to 16K fragment in man. Its relationship to ACTH. J Clin Endocrinol Metab. 1980; 51(1):182-4.
DOI: 10.1210/jcem-51-1-182.
View
19.
Lis M, Hamet P, Gutkowska J, Maurice G, Seidah N, Lariviere N
. Effect of N-terminal portion of pro-opiomelanocortin on aldosterone release by human adrenal adenoma in vitro. J Clin Endocrinol Metab. 1981; 52(6):1053-6.
DOI: 10.1210/jcem-52-6-1053.
View
20.
Mains R, Eipper B
. Coordinate synthesis of corticotropins and endorphins by mouse pituitary tumor cells. J Biol Chem. 1978; 253(3):651-5.
View